Sector portfolio · VC firm · United States
Section 32's Biotech portfolio
Section 32 has backed 12 Biotech startups in rounds we track, $2.2B between them, shown by the stage each has reached. The best-funded is Newlimit.
Funding by segment
- Stage not reported$883M3
- Series B$402M3
- Series A$32M2
- Series C and later$732M2
- Pre-seed and seed$114M2
Where they are based
- United States11$2.1B
- Ireland1$60M
United States
IrelandFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M4
- $50M to $250M3
- $250M to $1B4
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 12 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States11
- Ireland1
Startups by country, 2 countries in all.
Segment by segment
Stage not reported
3 startups · $883M raised
FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
CelularityCelularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.United States$270M
TeckroTeckro is an enterprise software company founded in 2015, headquartered in Limerick, Ireland, with additional offices in Dublin anIreland$60M
Series B
3 startups · $402M raised
Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.United States$310M
VinetiVineti is a healthcare technology company based in San Francisco, California, with additional offices in Bethesda, Maryland, and YUnited States$47M- CHCue HealthUnited States$45M
Series A
2 startups · $32M raised
Cradle GenomicsCradle Genomics is a biotechnology company based in San Diego, founded in 2018.United States$17M
Embark VeterinaryEmbark Veterinary is a Boston-based company specializing in canine genomics and biotechnology, founded in 2015.United States$15M
Series C and later
2 startups · $732M raised
NewLimitNewLimit is a biotechnology company based in South San Francisco, California, focused on extending human healthspan through innovaUnited States$610M
Aspen NeuroscienceAspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.United States$122M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Section 32 as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Section 32?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.